CFRA analyst Catherine Seifert upgraded Allstate's stock rating from 'Buy' to 'Strong Buy', maintaining a price target of $230.00. Seifert's valuation of Allstate (NYSE: ALL) shares is based on a ...

Lancaster Orthopedic Group signed an agreement with Penn State Health that took effect on Jan. 31. The practice’s three ...

BMO Capital Markets reiterated their Outperform rating on Allstate shares (NYSE: ALL) with a steady price target of $222.00.

Management aims to grow Property-Liability policies in force in 2025 by improving retention and driving strong new business sales. Efforts include proactive customer outreach to enhance affordability ...

Property and casualty insurer Allstate's fourth-quarter profit beat Wall Street expectations on Wednesday, helped by strong ...

The Northbrook-based insurer's size and geographic reach help protect it from regional disasters and give it pricing power.

Shares of The Allstate Co. (NYSE:ALL – Get Free Report) have been assigned an average rating of “Moderate Buy” from the ...

The Allstate Corporation has reached a definitive agreement to sell its group health business to Nationwide for $1.25 billion ...

More than a decade after exiting health insurance, Nationwide has agreed to acquire a fast-growing employer benefits business ...

U.S.-based insurer Allstate Corporation (ALL) has agreed to sell its Group Health business to its rival Nationwide for $1.25 billion in cash.

Allstate's group health business provides stop-loss insurance to small businesses, which will gain access to Nationwide's ...